13.64% w/w CBPI Flavored Chewable Tablet for Dogs

Merck Animal Health

Revision date : 2011-06-24

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

9005-25-8

Name of the chemical

Starch

Concentration

10-20

EC/CAS

25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

10-20

EC/CAS

57-50-1

Name of the chemical

Sucrose, pure C12H22O11

Concentration

<10

EC/CAS

56-81-5

Name of the chemical

glycerol

Concentration

<10

General Information

Revision date

2011-06-24

Product name

13.64% w/w CBPI Flavored Chewable Tablet for Dogs

Product Synonyms

13.64% w/w CBPI Flavored Chewable Tablet for Dogs BRAVECTO

Emergency telephone

(800) 424-9300, (703) 527-3887

Icons in SDS

Company Information

company name

Merck Animal Health

Section 2

SECTION 2: Hazards identification

OSHA EMERGENCY OVERVIEW Chewable tablet Light to dark brown Odor unknown May cause allergic reactions in susceptible individuals. May cause effects to: gastrointestinal tract cardiovascular system respiratory system kidney liver Very toxic to aquatic organisms.

Potential health effects

The toxicological properties of the mixture(s) have not been fully characterized in humans or animals. Therefore, laboratory or process control systems and appropriate work practices should be in place to minimize the potential for inhalation exposure, skin contact, eye contact, or ingestion when working with this material. The information presented below pertains to the following individual ingredients, and not to the mixture(s). CBPI produced reversible metabolic liver effects in oral and dermal animal studies including increased liver enzyme activity in blood plasma with decreased lipid and protein concentration, increased organ weight, and increased hepatocellular fatty change. Acute exposure to polyethelyene glycol may cause slight eye or skin irritation, abnormal taste, gas, nausea, vomiting, diarrhea, irregular heartbeat, low blood pressure, or fluid in the lungs. Repeated exposure of polyethylene glycol to damaged skin has been reported to cause kidney failure and necrosis. It may cause skin sensitization in sensitive individuals. Allergic skin reactions have been reported following ingestion of polyethylene glycol. LISTED CARCINOGENS

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.